UBS O'Connor’s Axonics, Inc. Common Stock AXNX Stock Holding History

UBS O'Connor’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,148,826	Closed	-$150M	–	609
2024 Q3	$150M	Sell	2,148,826 -48,454	-2%	-$3.32M	3.69%	9
2024 Q2	$148M	Buy	2,197,280 +251,360	+13%	+$16.9M	4.16%	6
2024 Q1	$134M	Buy	1,945,920 +1,897,614	+3,928%	+$128M	3.85%	6
2023 Q4	$3.01M	Sell	48,306 -2,370	-5%	-$133K	0.09%	119
2023 Q3	$2.84M	Sell	50,676 -3,000	-6%	-$169K	0.05%	181
2023 Q2	$2.71M	Buy	53,676 +2,644	+5%	+$141K	0.06%	214
2023 Q1	$2.78M	Sell	51,032 -2,570	-5%	-$150K	0.07%	217
2022 Q4	$3.35M	Buy	53,602 +20,989	+64%	+$1.39M	0.06%	293
2022 Q3	$2.3M	Hold	32,613	–	–	0.03%	599
2022 Q2	$1.85M	Buy	32,613 +22,913	+236%	+$1.26M	0.02%	671
2022 Q1	$607K	Buy	+9,700	New	+$523K	0.01%	738

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS O'Connor's AXNX Position: Q4 2024 in Review

UBS O'Connor sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 2,148,826 shares — an estimated $150M sold.

UBS O'Connor first reported a position in AXNX in Q1 2022 and held it in 11 quarters. The position peaked at $150M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

UBS O'Connor reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
UBS O'Connor sold 2,148,826 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $150M.
UBS O'Connor first reported a position in Axonics, Inc. Common Stock in Q1 2022 and held it in 11 quarters.
UBS O'Connor's Axonics, Inc. Common Stock position peaked at $150M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.